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Abstract
Background: Two deoxysugar glycosyltransferases (GTs),
UrdGT1b and UrdGT1c, involved in urdamycin biosynthesis
share 91% identical amino acids. However, the two GTs show
different specificities for both nucleotide sugar and acceptor
substrate. Generally, it is proposed that GTs are two-domain
proteins with a nucleotide binding domain and an acceptor
substrate site with the catalytic center in an interface cleft between
these domains. Our work aimed at finding out the region
responsible for determination of substrate specificities of these
two urdamycin GTs.
Results : A series of 10 chimeric GT genes were constructed
consisting of differently sized and positioned portions of urdGT1b
and urdGT1c. Gene expression experiments in host strains
Streptomyces fradiae Ax and XTC show that nine of 10 chimeric
GTs are still functional, with either UrdGT1b- or UrdGT1c-like
activity. A 31 amino acid region (aa 52^82) located close to the
N-terminus of these enzymes, which differs in 18 residues, was
identified to control both sugar donor and acceptor substrate
specificity. Only one chimeric gene product of the 10 was not
functional. Targeted stepwise alterations of glycine 226 (G226R,
G226S, G226SR) were made to reintroduce residues conserved
among streptomycete GTs. Alterations G226S and G226R
restored a weak activity, whereas G226SR showed an activity
comparable with other functional chimeras.
Conclusions: A nucleotide sugar binding motif is present in the
C-terminal moiety of UrdGT1b and UrdGT1c from S. fradiae. We
could demonstrate that it is an N-terminal section that determines
specificity for the nucleotide sugar and also the acceptor substrate.
This finding directs the way towards engineering this class of
streptomycete enzymes for antibiotic derivatization applications.
Amino acids 226 and 227, located outside the putative substrate
binding site, might be part of a larger protein structure, perhaps a
solvent channel to the catalytic center. Therefore, they could play
a role in substrate accessibility to it. ß 2001 Elsevier Science Ltd.
All rights reserved.
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1. Introduction
The biosynthesis of polysaccharides, complex carbohy-
drates and other glycosylated cellular metabolites is of
major importance, since these molecules are directly in-
volved in numerous biological and cellular processes [1].
Glycobiology ranges from storage of photosynthetic prod-
ucts, cell^cell recognition and adhesion as well as glyco-
sylation of proteins. Vaccinations and pathogenicity are
also glycosylation-based processes. Within the pharma-
ceutical sciences, glycosylated secondary metabolites and
especially polyketides have attracted attention since they
exhibit potent antibacterial activity. The biosynthesis of
oligo- and polysaccharides is catalyzed by glycosyltransfer-
ases (GTs), which transfer sugar residues from a donor
substrate, usually a nucleotide sugar, to an aglycone or a
growing carbohydrate chain. Donor and acceptor sub-
strate speci¢cities are the key to the structural diversity
of saccharides produced by a cell [2,3].
So far, a large number of GTs from both prokaryotic
and eukaryotic sources has been characterized, re£ecting
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the wide range of substrates. Mechanistically, GTs can be
categorized into two main subgroups, inverting and retain-
ing enzymes, since they form glycosidic bonds by either
inverting or retaining the anomeric con¢guration. Se-
quence comparison shows that GTs are divergent in their
primary structure, but frequently share common motifs
[3]. Based on these ¢ndings a sophisticated approach for
classi¢cation is the CAZy system, by now expanded to
51 GT families [4]. Following this classi¢cation, the en-
zymes UrdGT1b and UrdGT1c described in this publica-
tion, along with other GTs coded in streptomycete natural
product biosynthetic gene clusters, belong to CAZy family
1. It contains inverting GTs also of viral, bacterial, plant
or fungal origin as well as invertebrate and vertebrate GTs
including mammalian and human glucuronosyltransferase
families. Widespread among many families is the so-called
DXD motif [5^11] of two aspartic acid residues, £anked
N-terminally by apolar residues. A common nucleotide
binding motif is a sequence covering about 40 amino acids
with some highly conserved residues [12^14]. In the con-
text of streptomycete antibiotic biosynthesis, CAZy family
1 streptomycete enzymes have been characterized [15^23],
among them UrdGT1b and UrdGT1c of the urdamycin
biosynthetic gene cluster. Urdamycin A (Fig. 1), produced
by Streptomyces fradiae Tu«2717, is an angucycline-type
antibiotic and bears a trisaccharide unit (D-olivose-L-rho-
dinose-D-olivose) attached C-glycosidically to the polyke-
tide core at C9, and an O-glycosidically appended single
L-rhodinose at C12b [24]. Four GT genes, urdGT1a,
urdGT1b, urdGT1c (GenBank accession number
AF164961), and urdGT2 (GenBank accession number
AF164960), have been detected within the urdamycin bio-
synthetic gene cluster, and a speci¢c function during urda-
mycin biosynthesis could be assigned to each gene product
[21,22]. UrdGT1a and UrdGT2 are involved in the forma-
tion of compound 100-2 (Fig. 1), and UrdGT1c transfers
dNDP-L-rhodinose to compound 100-2 forming an
K-(1,3)-glycosidic bond. UrdGT1b completes urdamycin
A biosynthesis by attaching a dNDP-D-olivose to urdamy-
cin G (Fig. 1) via a L-(1,4)-glycosidic bond. Both enzymes
follow an inverting mechanism. It has been demonstrated
that UrdGT1c and UrdGT1b both accept intermediates as
substrates which lack the L-rhodinose at position 12b:
aquayamycin (Fig. 1) or urdamycinone B [25] in the case
of UrdGT1c, and 12b-derhodinosyl-urdamycin G (Fig. 1)
or compound 100-1 [25] in the case of UrdGT1b. Interest-
ingly, despite di¡erent functions and substrate speci¢cities
UrdGT1b and UrdGT1c are strikingly highly homolo-
Fig. 1. Urdamycin A and its precursors and derivatives. Arrows indicate the biosynthetic steps catalyzed by the GTs UrdGT1b and UrdGT1c.
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gous, with 91% identity at the amino acid level. Conse-
quently, we harnessed this enzyme pair UrdGT1b/
UrdGT1c to locate and con¢ne regions that determine
the speci¢cities of these enzymes. Recently, we described
the generation of a mutant of S. fradiae lacking both
urdGT1b and urdGT1c but containing instead on its chro-
mosome a chimeric gene consisting of 715 nucleotides
from urdGT1b and 458 nucleotides from urdGT1c. The
gene product, UrdGT1b-1c, in this contribution referred
to as chimera 6, which di¡ers from UrdGT1b in six amino
acids in the C-terminal moiety, was active and catalyzed
the same reaction as UrdGT1b [22]. We now describe the
construction of a set of chimeric GT genes. To test the
catalytic activities of the functional gene products these
genes were expressed in di¡erent GT mutants of S. fradiae
Tu«2717. We identi¢ed a constricted region of 31 aa within
UrdGT1b and UrdGT1c (aa 52^82, di¡ering in 18 posi-
tions) which controls the substrate speci¢city of both en-
zymes.
2. Results and discussion
2.1. Sequence comparison of UrdGT1b and UrdGT1c, and
construction of chimeric genes
The urdamycin biosynthetic gene cluster has been
cloned and sequenced, and numerous genes have been
identi¢ed [21,22,26,27]. To determine the function of
four GT genes, inactivation and expression experiments
were performed previously [22]. Sequence comparison of
UrdGT1b (dNDP-L-rhodinose:urdamycin G glycosyl-
transferase) and UrdGT1c (dNDP-D-olivose:100-2 glyco-
syltransferase) revealed that both enzymes share 91% iden-
tical amino acids (Fig. 2). To determine which region of
these two GTs would govern speci¢city we constructed a
set of chimeric GT genes in which di¡erently sized and
positioned elements of one parental gene (urdGT1c) had
been replaced by the equivalent of the second parental
gene (urdGT1b) or vice versa. The regions to be swapped
among the two genes are de¢ned by restriction sites com-
mon to both genes (P£MI, nucleotides 84^94; PstI, nu-
cleotides 547^552; BsmI, nucleotides 716^721 in urdGT1b
and 713^718 in urdGT1c) thus making it possible to clone
sequence regions I (nucleotides 1^94, amino acids 1^31), II
(nucleotides 95^552, amino acids 32^184), III (nucleotides
553^721 in urdGT1b and 553^718 in urdGT1c, amino acids
185^240 in UrdGT1b and 185^239 in UrdGT1c) and IV
(nucleotides 722^1167 in urdGT1b and 719^1176 in
urdGT1c, amino acids 241^388 in UrdGT1b and 240^391
in UrdGT1c). Region II was subdivided into region IIa
(nucleotides 95^249, amino acids 32^83) with 18 out of
50 amino acids di¡erent, and region IIb (nucleotides
250^552, amino acids 84^184) with perfect amino acid
identity. Ten chimeric genes were constructed representing
di¡erent combinations of regions of urdGT1b and
urdGT1c (Fig. 3). Additionally, one of the chimeras (chi-
mera 4) was further edited by three di¡erent pinpoint mu-
tations leading to targeted amino acid substitutions.
2.2. Generation of a suitable host for testing for
UrdGT1b-like activity
UrdGT1c-like activity of chimeric GTs was tested by
expressing each individual chimeric gene in mutant Ax
[22]. This mutant, de¢cient for urdGT1a, urdGT1b and
urdGT1c, predominantly accumulates aquayamycin and,
less prominently, urdamycinone B. The latter is converted
to compound 100-1, and aquayamycin to 12b-derhodino-
syl-urdamycin G, when urdGT1c is expressed in this mu-
tant. To test UrdGT1b-like activity, we generated mutant
XTC. This mutant lacks urdGT1a and urdGT1b but con-
tains urdGT1c under the control of the ermE promoter
integrated back into the chromosome of mutant Ax. Ex-
pected integration and gene expression were con¢rmed by
the production of mainly 12b-derhodinosyl-urdamycin G.
In lower amounts, the previously described urdamycin N
Fig. 2. Comparison of amino acid sequences of the GTs UrdGT1b
(upper line) and UrdGT1c (lower line). Non-identical amino acids are
shown in bold, asterisks indicate lacking amino acids. Region I: aa 1^
31; region IIa: aa 32^83; region IIb: aa 84^184; region III: aa 185^240
in UrdGT1b and aa 185^239 in UrdGT1c; region IV: aa 241^388 in
UrdGT1b and aa 240^391 in UrdGT1c.
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was also present [27]. When the wild-type gene urdGT1b
was expressed in mutant XTC 12b-derhodinosyl-urdamy-
cin A was the major product (Fig. 1, HPLC pro¢les shown
in Fig. 4).
2.3. Expression of the chimeric genes in mutant Ax:
conversion of UrdGT1b into UrdGT1c
Mutant Ax was transformed with chimeras 1^5 and 7^
10. No conversion of aquayamycin and urdamycinone B
was observed when chimeras 2, 4, 8 and 9 were expressed
indicating that products of these chimeric genes either
acted like UrdGT1b or were not active at all. In contrast,
expression of chimeras 1, 3, 5, 7 and 10 led to the pro-
duction of 12b-derhodinosyl-urdamycin G and compound
100-1 indicating that they were functional like UrdGT1c
(Fig. 4). These results revealed that changes in regions I,
III and IV did not a¡ect substrate speci¢city of UrdGT1c.
When regions I and II of UrdGT1b were simultaneously
replaced by their equivalents from UrdGT1c (chimera 3),
UrdGT1b activity switched over to UrdGT1c activity. The
same observation was made with chimera 7, where regions
II and III of UrdGT1b were replaced by those of
UrdGT1c. In addition, chimera 10, which is UrdGT1b
engineered such that it carries merely region IIa of
UrdGT1c origin, shows UrdGT1c-like activity as well.
These ¢ndings demonstrate that region IIa located within
the N-terminal region of the enzyme governs both nucle-
otide sugar and acceptor substrate speci¢city in UrdGT1c,
and that functionality is maintained regardless of where
the other regions originate from. However, a putative nu-
cleotide binding motif was found to reside within the
C-terminal region of UrdGT1b and UrdGT1c. This motif
is found among human UDP-glucuronosyltransferases,
with a smaller degree of conservation it is also present in
the £avonol O(3)-glucosyltransferase from Zea mays,
Streptomyces lividans macrolide GT, other CAZy family
1 members and other families [12,13]. Data from the crys-
tal structure of MurG, an Escherichia coli peptidoglycan
GT of CAZy family 28, con¢rm this motif to be involved
in nucleotide binding [14]. Other crystallographic studies
have been published on phage T4 L-glucosyltransferase
[28,29], SpsA from Bacillus subtilis [30], the bovine L-1,4-
galactosyltransferase T1 [31], and the rabbit N-acetylglu-
cosaminyltransferase I, [9], as well as the structure of amy-
lomaltase from Thermus aquaticus [32] and an engineered
cyclodextrin glucanotransferase from Bacillus sp. [33], to
reveal structure^mechanism relationships and also con-
¢rmed the notion of the two-domain character of these
enzymes.
For the T4 L-glucosyltransferase and the topologically
identical and structurally similar enzyme MurG of E. coli,
the sugar within the enzyme could not be detected but its
position was modelled. MurG binds the UDP-N-acetylglu-
cosamine into a pocket in the C-domain, and for some
conserved residues a possible role was suggested. It was
predicted, for example, that glutamine 289 of MurG is
positioned in hydrogen bonding distance and interacts
with the hydroxyl group at C4 of the sugar, which could
be the reason why UDP-glucosamine is accepted as a sub-
strate, but not the isomeric UDP-galactosamine [14].
Analogously, we speculate that in the case of UrdGT1c
amino acids of region IIa serve as possible sterical sensors
towards the donor sugar substrate, which would require
an interaction of the N- and C-terminal moieties with the
nucleotide-bound sugar before catalysis is initiated. Based
on the modelling of the sugar binding site of T4 L-gluco-
syltransferase, the glucose resides in a pocket, surrounded
by both nucleotide moiety and amino acid residues of both
domains [29]. Additional support for our assumption of
an N-terminal domain interacting with the sugar is lent by
earlier studies on the human UDP-glucuronosyltransferase
2B4. It was demonstrated that the nucleotide diphosphate
binds at the C-terminal moiety, whereas the sugar inter-
acts with the amino-terminal part of the enzyme [13,34].
Another motif which is highly conserved among many
Fig. 3. Comparison of chimeric and wild-type GTs constructed during
this study. Protein regions are indicated by roman numerals, vertical
lines represent the borders, numbers on top indicate the corresponding
amino acid residues referred to UrdGT1b wild-type sequence.
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GTs is the DXD motif. The consensus is described as
hhhhDxDxh, with ‘h’ denoting a hydrophobic residue. It
has been shown that the ¢rst aspartic acid is necessary to
bind the donor sugar, the second highly conserved aspartic
acid participates in coordination of a divalent metal cat-
ion, necessary to counter the negative charge of the
L-phosphate [9^11]. In UrdGT1b and UrdGT1c this motif
is present as LxD (165GLAGLPDPA173) which is consis-
Fig. 4. Selected HPLC chromatograms. (a) S. fradiae strain Ax. (b) Ax expressing urdGT1c. (c) S. fradiae strain XTC. (d) Ax expressing chimera 7.
Identical pro¢les were obtained with chimeras 1, 3, 5, and 10. (e) XTC expressing non-functional chimera 4. (f) XTC expressing urdGT1b. (g) XTC ex-
pressing chimera 2. Identical pro¢les were obtained with chimeras 8 and 9. (h) XTC expressing chimera 11. (i) XTC expressing chimera 12. (j) XTC ex-
pressing chimera 13. Except urdamycin N [27] no shunt or follow-up products are indicated.
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tent with the ¢nding that the ¢rst residue of DXD may
vary, whereas the second is strongly conserved. However,
for ExoM, involved in exopolysaccharide synthesis of Si-
norhizobium meliloti, which also possesses the DXD motif,
it was shown in vitro that only the ¢rst, but not the second
aspartic acid is crucial for enzymatic activity [8].
2.4. Expression of the chimeric genes in mutant XTC:
conversion of UrdGT1c into UrdGT1b
Chimeras 1^5 and 7^10 were also used to transform
mutant XTC to screen for UrdGT1b-like activity. Expres-
sion of chimeras 1, 3, 5, 7, and 10 did not alter the spec-
trum of urdamycin-type metabolites in the host strain. We
anticipated this ¢nding as the products of these chimeric
genes have been shown to act like UrdGT1c (see above).
However, 12b-derhodinosyl-urdamycin A was the major
compound produced by mutant XTC expressing either
chimera 2, 8, or 9 (Fig. 4). This indicates that these gene
products possess UrdGT1b-like features. The product of
chimera 4 did not show any UrdGT1b-like activity (Fig. 4)
nor did it act like UrdGT1c. Thus we had to assume that
this particular enzyme is not functional. In contrast, chi-
mera 9, which is very similar to chimera 4 but contains
region IV of UrdGT1b instead of UrdGT1c, was func-
tional and acted as UrdGT1b. The UrdGT1b-like activity
of chimera 6 has been reported earlier [22]. These results
demonstrate that region IIa also determines substrate
speci¢city for nucleotide sugar and acceptor in the case
of UrdGT1b. In contrast to UrdGT1c-like enzymes,
UrdGT1b-like enzymes additionally need region III (chi-
mera 8) or IV (chimera 9) of UrdGT1b origin for enzy-
matic functionality. Therefore, UrdGT1b seems to be less
tolerant of sequence alterations than UrdGT1c.
After having shown the individual speci¢city of each
chimeric GT we were interested to determine their cata-
lytic activity compared with the wild-type parental en-
zymes. HPLC pro¢les of the metabolites allowed us to
estimate whether acceptor substrates (aquayamycin and
urdamycinone B for UrdGT1c, 12b-derhodinosyl-urdamy-
cin G and compound 100-1 for UrdGT1b) would disap-
pear due to quantitative enzymatic conversion. We found
that the wild-type enzyme UrdGT1c and all chimeras spe-
ci¢c like UrdGT1c quantitatively converted aquayamycin
and urdamycinone B to 12b-derhodinosyl-urdamycin G
and compound 100-1, respectively (Fig. 4). In contrast,
none of the UrdGT1b-like chimeras was able to totally
convert its substrates into 12b-derhodinosyl-urdamycin A
and urdamycin B whereas the wild-type enzyme UrdGT1b
was (Fig. 4). Again, UrdGT1b appears to be more sensi-
tive to engineering than UrdGT1c.
2.5. Conversion of the non-functional chimera 4 into
functional chimeras 10, 11 and 12
The gene product of chimera 4 acted neither like
UrdGT1b nor like UrdGT1c indicating that it was not
functional, whereas the product of chimera 6 showed
UrdGT1b-like activity. Both gene products di¡er in three
amino acid positions of region III: leucine versus valine
(aa 221); isoleucine versus leucine (aa 224); glycine versus
serine-arginine (aa 226 and 226^227). To explore the pos-
sibility of refunctionalization, we edited chimera 4 in three
di¡erent ways such that the codon for glycine was re-
placed by codons for serine, arginine, or both, resulting
in chimera 11 (G226S), chimera 12 (G226R) and chimera
13 (G226SR). We focused on these particular amino acids
since numerous deoxysugar GTs possess, following a con-
served glycine, at least either a serine (rarely a threonine)
or an arginine or even both amino acids in the positions
occupied by a second glycine in UrdGT1c or by serine and
arginine in UrdGT1b. Among these GTs are LanGT1,
LanGT2 and LanGT3 of the landomycin cluster [35],
those for erythromycin [36,37], megalomicin [38], mithra-
mycin [39,40] and oleandomycin biosynthesis [41],
GraOrf14 of the granaticin cluster [42] and DnrS/DnmS
of the daunorubicin biosynthetic pathway [15,43]. When
expressed in XTC, the product of chimeras 11 and 12
showed a weak UrdGT1b-like activity yielding low
amounts of 12b-derhodinosyl-urdamycin A (Fig. 4). It
was present at a maximum 1:9 ratio of product to accep-
tor substrate (12b-derhodinosyl-urdamycin G). However,
when chimera 13 was expressed in XTC, we found that
refunctionalization was fully accomplished (Fig. 4). Chi-
mera 13 is highly and comparably active like the
UrdGT1b-type chimeras 2, 6, 8, and 9. Obviously, the
region in which the edited amino acid positions are located
is crucial, not for speci¢city itself, but for activity in con-
cert with region IIa. For full olivosyltransferase activity
both amino acids in question, serine and arginine, are
required. Conversely, chimera 9 acts fully like UrdGT1b
without these amino acids but having instead a glycine in
position 226. In addition to the importance of region IIa
mentioned earlier, a possible role of region III of
UrdGT1b and UrdGT1c, particularly of the serine and
arginine residues, can be explained assuming a larger in-
ternal structure, e.g. a solvent channel. In the rabbit
N-acetylglucosaminyltransferase I [9] and T4 L-glucosyl-
transferase [28,29] amino acids building up a channel
structure are known. Such a channel might have been
disturbed or completely destroyed in chimera 4. An extra
hydroxyl group of D-olivose, compared with L-rhodinose,
could require hydrogen bonding, or coordination of water
molecules to ¢t the binding site appropriately. Arginine
227 may be crucial for a conformational change upon
substrate binding to initiate interdomain salt bridges
which cannot be set up adequately under the combination
of regions III and IV while IIa is of di¡erent origin. The
conformational conversion of a GT has been studied in
detail, e.g. for T4 L-glucosyltransferase [28]: three arginine
residues were shown to be involved in hydrogen bonding
of nucleotide phosphate groups, with two of them also
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implicated in interdomain salt bridges. Thus, substrate
binding and conformational change are synchronized [29].
The region swapping technique was previously shown to
be successful for similar enzyme pairs to assign features to
a restricted enzymatic region. This includes e.g. locating
functional domains in terpene cyclases [44] or triterpene
synthases of plant origin [45], xylanases from prokaryotic
sources [46] as well as identifying a dimerization domain in
dehalogenases [47] and substrate speci¢city conferring do-
mains in dioxygenases for degradation of aromatic sub-
stances [48]. Furthermore, with this approach enzyme
properties such as thermostability, pH optima or chaper-
one-like activity [49^51] were enhanced after region swap-
ping experiments. In the ¢eld of modularly organized en-
zymes, this technique was used e.g. to create arti¢cial non-
ribosomal peptide synthetases [52]. In our work we applied
the region swapping strategy to Streptomyces genes in-
volved in antibiotic biosynthesis. It was demonstrated
that only one region (IIa) with 18 amino acids variable
among UrdGT1b and UrdGT1c is responsible for enzy-
matic speci¢city. A second region (III) has been identi¢ed
as crucial for activity. Thus, future pinpoint mutation
work in this system UrdGT1b/UrdGT1c, especially within
region IIa, should shed light on the question which amino
acids act as determinants or sensors for substrate speci¢c-
ity. For human GTs involved in formation of the histo-
blood group ABO(H) antigens it has already been shown
that one single amino acid decides donor sugar speci¢city
[53]. With nine of 10 active, the ratio of functional chime-
ras was very high, and each one showed either one or the
other parental speci¢city. When it switched over, we al-
ways observed an all-or-nothing exchange. None of the
chimeras possesses a dual or relaxed speci¢city. The only
non-functional chimera (chimera 4) resumed working after
slightly editing its primary sequence. GTs are important
tools in combinatorial biosynthesis approaches since
deoxysugars frequently play a crucial role for bioactivity
of natural products, such as antibiotics and anticancer
agents. Several cases of GTs with bifunctional or relaxed
activity, although involved in very speci¢c glycosylation
processes, have been described [27,54,55]. Therefore, de-
sign of GTs with an altered or broader speci¢city seems
to be a feasible task to generate a library of molecules with
greater structural diversity, leading to the development of
new drugs.
3. Signi¢cance
Glycosyl transfer is a cellular process of major impor-
tance. A combined crystallographic and computational ap-
proach identi¢ed GTs as two-domain enzymes with an
acceptor substrate binding site and a nucleotide sugar
binding motif. The present work aimed to further explore
the genetic basis of urdamycin production in S. fradiae
Tu«2717. Two highly homologous GT genes, yet encoding
enzymes of di¡erent speci¢cities, were used as source
genes to generate and express a series of chimeric GT
genes. We could demonstrate that it is an N-terminally
located region of 31 amino acids that confers both accep-
tor substrate and donor nucleotide sugar speci¢city. This
¢nding provides novel opportunities for future engineering
of GTs as tailoring enzymes to eventually generate novel
pharmacologically active metabolites in streptomycete
hosts. In addition, a serine-arginine motif (226SR227 in
UrdGT1b) conserved among streptomycete GTs was iden-
ti¢ed as the residues responsible for D-olivose transfer. The
only non-functional chimera, in which this motif was
obscured, regained olivosyltransferase activity by engineer-
ing either Ser or Arg into the primary sequence. Full
activity was restored when both amino acids were intro-
duced.
4. Materials and methods
4.1. Strains, growth conditions, media and vectors
For standard purposes, S. fradiae Tu«2717 (wild-type) and mu-
tant strains Ax and XTC were grown on 1% malt extract, 0.4%
yeast extract, 0.4% glucose and 1 mM CaCl2, pH adjusted to 7.2
(HA medium), prepared as solid or liquid medium, at 28‡C. For
maintenance of mutant XTC, apramycin was added to a ¢nal
concentration of 25 Wg/ml. For urdamycin production NL 111V
liquid medium (20 ml in a single ba¥ed 100-ml Erlenmeyer £ask)
was used. Incubation was done at 28‡C and 160 rpm for 5^6
days. DNA manipulation was carried out in E. coli XL-1 Blue
MRFP (Stratagene). Before transforming S. fradiae mutants Ax
and XTC plasmids were propagated in E. coli ET 12567 (dam3,
dcm3, hsdS, CmR) [56] to obtain unmethylated DNA. E. coli
strains were grown on Luria^Bertani (LB) agar or liquid medium
containing the appropriate antibiotic for selection. Vector pBlue-
script SK3 (pBSK3) was from Stratagene, pUC19 was from New
England Biolabs. For expression of chimeric GT genes, vector
pUWL201 (courtesy of Prof. W. Piepersberg and Dr. U. Weh-
meyer, University of Wuppertal, Germany) conferring thiostrep-
ton and ampicillin resistance was employed. For the gene inte-
gration procedure to generate mutant XTC, pSET152 was used,
which confers resistance to apramycin [57].
4.2. General techniques, DNA sequencing and genetic manipulation
of Streptomyces
Standard molecular biology procedures were performed as de-
scribed [58]. Isolation of plasmid DNA from E. coli and DNA
restriction/ligation were performed following the protocols of the
manufacturers of kits, enzymes, and reagents (Amersham Phar-
macia, Macherey-Nagel, New England Biolabs, Promega). Strep-
tomyces protoplast preparation, transformation, and protoplast
regeneration were performed as described [59]. Nucleotide se-
quences of the chimeric genes were determined by the dideoxy
chain termination method using an automatic laser £uorescence
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DNA sequencer (Molecular Dynamics Vistra 725). Sequencing
reactions were done using a thermosequenase cycle sequencing
kit with 7-deaza-dGTP (Amersham Pharmacia) and standard
primers (M13 universal and reverse, T3, T7). PCR reactions
were done on a Perkin Elmer GeneAmp 2400 thermal cycler.
4.3. Construction of S. fradiae XTC mutant
pUWLurdGT1c [22] was subjected to KpnI/XbaI restriction
digestion to obtain a 1.6-kb fragment that covers the complete
reading frame urdGT1c as well as the ermE promoter sequence.
This fragment was inserted in the multiple cloning site of pUC19
cleaved with the same enzymes. This plasmid was named pUC19-
1cerm. Then, urdGT1c and ermE promoters were excised by
EcoRI restriction and ligated into pSET152 to create gene inte-
gration plasmid pSET-1cerm. It was deployed to transform pro-
toplasts of S. fradiae Ax mutant. The transformation procedure
resulted in about 30 apramycin-resistant colonies per Wg DNA.
One clone, now referred to as mutant XTC, was chosen for fur-
ther experiments.
4.4. Construction of chimeric GT genes
Plasmids pUWLurdGT1b and pUWLurdGT1c are pUWL201-
based constructs containing the GT genes urdGT1b and urdGT1c,
respectively, and have been described [22]. After cloning in
pBSK3, all chimeric genes mentioned below were sequenced to
con¢rm the intended construction.
4.5. Construction of chimera 1 and chimera 2
Plasmids pUWLurdGT1b (pUWLurdGT1c) each possess two
restriction sites for P£MI. Restriction of these plasmids with this
enzyme resulted in 1.1- and 6.7-kb fragments. Along vector DNA
the 1.1-kb fragment represents the ¢rst 31 codons of the GT gene
urdGT1b (urdGT1c), whereas codons 32^388 of urdGT1b (32^391
of urdGT1c) are located on the 6.7-kb fragment. The 1.1-kb
P£MI fragment of pUWLurdGT1b (pUWLurdGT1c) was ligated
to the 6.7-kb P£MI fragment of pUWLurdGT1c (pUW-
LurdGT1b) to generate chimera 1 (chimera 2). The HindIII/
XbaI fragment containing the chimeric gene was ligated into
pBSK3 to generate chimera 1b (chimera 2b).
4.6. Construction of chimera 3 and chimera 4
pUWLurdGT1b (pUWLurdGT1c) was co-restricted by PstI/
BglII to create a 0.65-kb PstI-BglII fragment comprising codons
185^388 of urdGT1b (185^391 of urdGT1c) and a 7.15-kb BglII-
PstI fragment which represents the vector pUWL201 moiety and
codons 1^184 of urdGT1b (1^184 of urdGT1c). The 0.65-kb PstI-
BglII fragment of pUWLurdGT1b (pUWLurdGT1c) was then
ligated to the 7.15-kb BglII-PstI fragment carrying the portion
of urdGT1c (urdGT1b) to reconstitute complete plasmids but car-
rying a hybrid reading frame now referred to as chimera 3 (chi-
mera 4). The HindIII/XbaI fragment containing the chimeric gene
was ligated into pBSK3 to generate chimera 3b (chimera 4b).
4.7. Construction of chimera 5
pUWLurdGT1c was restricted by BsmI/XbaI digestion to ob-
tain the 7.15-kb fragment that contains codons 1^239 of
urdGT1c. pUWLurdGT1b was restricted equally but now the
0.65-kb fragment representing codons 241^388 of urdGT1b was
used for the further cloning procedure. It was ligated to the 7.15-
kb BsmI/XbaI fragment to generate chimera 5. The HindIII/XbaI
fragment containing the chimeric gene was ligated into pBSK3 to
generate chimera 5b.
4.8. Construction of chimera 6
The construction of the chromosomal mutant 16-14, here re-
ferred to as chimera 6, has been described [22]. This mutant lacks
both urdGT1b and urdGT1c but contains a chromosomally lo-
cated chimeric gene consisting of 715 nucleotides from urdGT1b
and 458 nucleotides from urdGT1c.
4.9. Construction of chimera 7 and chimera 8
Chimera 1 (chimera 2) was restricted with BsmI/XbaI to create
a 7.15-kb BsmI-XbaI fragment which represents the vector
pUWL201 moiety and codons 1^238 of chimera 1 (1^239 of chi-
mera 2). Subsequently, pUWLurdGT1b (pUWLurdGT1c) was
restricted with BsmI/XbaI to create a 0.65-kb fragment compris-
ing codons 240^388 of urdGT1b (240^391 of urdGT1c). The 0.65-
kb BsmI/XbaI fragment of pUWLurdGT1b (pUWLurdGT1c)
was then ligated to the 7.15-kb BsmI/XbaI fragment of chimera
1 (chimera 2) to generate chimera 7 (chimera 8), which possesses
aa 1^31 and 239^388 of UrdGT1b, and aa 32^238 of UrdGT1c
(aa 1^31 and 239^391 of UrdGT1c, and 32^239 of UrdGT1b).
The HindIII/XbaI fragment containing the chimeric gene was
ligated into pBSK3 to generate chimera 7b (chimera 8b).
4.10. Construction of chimera 9
Chimera 3 and chimera 4 were restricted by XbaI/BsmI diges-
tion to obtain a 7.15-kb fragment of chimera 3 and a 0.65-kb
fragment of chimera 4. The 7.15-kb fragment contains codons 1^
238 of chimera 3 and the 0.65-kb fragment codons 240^388 of
chimera 4. Ligation of these two DNA fragments created a chi-
meric GT gene whose codons 1^184 and 240^388 originate from
urdGT1b, whereas codons 185^239 are derived from urdGT1c.
The HindIII/XbaI fragment containing the chimeric gene was
ligated into pBSK3 to generate chimera 9b.
4.11. Construction of chimera 10
Chimera 7 (pUWLurdGT1b) was co-restricted with PstI/BglII
to obtain a 7.15-kb fragment representing the vector pUWL201
and codons 1^184 of chimera 7 (a 0.65-kb fragment of urdGT1b
with the codons 185^388). The fragments were ligated to each
other to create chimera 10, the HindIII/XbaI fragment containing
the chimeric gene was ligated into pBSK3 to generate chimera
10b.
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4.12. Construction of chimeras 11, 12 and 13 by pinpoint mutations
in chimera 4
To replace glycine 226 of the gene product of chimera 4 by a
serine, an arginine, or both amino acids, oligonucleotide primers
LHS-1 (5P-CGCCCACAGAATGCCCCGCATCAACGGCACC-
CCGTTCAACGCCAACGTACTACCGATGGTGAC-3P), LHS-
2 (5P-CGCCCACAGAATGCCCCGCATCAACGGCACCCCG-
TTCAACGCCAACGTCCGACCGATGGTGAC-3P) and LHS-3
(5P-CGCCCACAGAATGCCCCGCATCAACGGCACCCCGT-
TCAACGCCAACGTCCGACTACCGATGGTGAC-3P) were
designed such that this particular codon is altered from GGC
(Gly) to AGT (Ser) by primer LHS-1, CGG (Arg) by primer
LHS-2 and AGTCGG (Ser-Arg) by primer LHS-3. The BsmI
site used for the cloning procedure is underlined, the altered
nucleotides are shown in bold. Using chimera 4b as template
0.75-kb fragments were ampli¢ed by PCR using Taq DNA poly-
merase and primers LHS-1, LHS-2 or LHS-3 and primer T7
(Stratagene). PCR conditions were as follows: initial denaturing
97‡C for 7 min, denaturing at 95‡C for 90 s, primer annealing at
49‡C for 60 s, polymerization at 72‡C for 60 s, 30 cycles, after-
wards an additional 10 min at 72‡C. The BsmI/HindIII restricted
PCR products were then used to replace the equivalent section in
chimera 4b generating chimera 11b (containing the serine codon),
chimera 12b (containing the arginine codon) and chimera 13b
(containing both the serine and arginine codons). Proper ligation
and codon alteration were con¢rmed by DNA sequencing. Chi-
meras 11, 12 and 13 were generated by subcloning the HindIII/
XbaI fragments containing the chimeric genes into pUWL201.
4.13. Chemical analysis of urdamycin derivatives
Aliquots (3 ml) of production cultures of S. fradiae strains Ax
and XTC expressing the di¡erent chimeric GT genes were ex-
tracted with an equal volume of ethyl acetate. The solvent was
evaporated to dryness in a speedvac centrifuge, then the dried
extracts were redissolved in methanol. TLC analysis was carried
out on silica gel plates (silica gel 60 F254, Merck) with methylene
chloride/methanol/ethyl acetate (8:1:1, v/v) as solvent. HPLC
analysis was performed on a Tosoh SC-8020 liquid chromato-
graph with a photodiode array detector and a Tosoh TSK gel
ODS-80TM (150U4.6 mm). The detection wavelength range was
250^500 nm, the gradient was: solvent A: 0.5% AcOH in H2O,
solvent B: 0.5% AcOH in CH3CN, non-linear gradient, 0^95% B
within 30 min at a £ow rate of 0.8 ml/min. LC/MS was performed
on a Thermoquest LCQ equipped with Hewlett Packard HP1000
series LC under the identical conditions described for HPLC, by
atmospheric pressure chemical ionization and detection in the
positive and negative mode. Urdamycins were identi¢ed by
HPLC-UV and mass spectrometry.
Acknowledgements
We are grateful to Prof. Dr. J. Rohr, Medical Univer-
sity of South Carolina, Charleston, SC, USA, for provid-
ing samples of urdamycin derivatives. This work was sup-
ported by a grant of the European Union (QLRT-1999-
00095) to A.B.
References
[1] A.C. Weymouth-Wilson, The role of carbohydrates in biologically
active natural products, Nat. Prod. Rep. 14 (1997) 99^110.
[2] J.C. Paulson, K.J. Colley, Glycosyltransferases, J. Biol. Chem. 264
(1989) 17615^17618.
[3] J.A. Campbell, G.J. Davies, V. Bulone, B. Henrissat, A classi¢cation
of nucleotide-diphospho-sugar glycosyltransferases based on amio
acid sequence similarities, Biochem. J. 326 (1997) 929^942.
[4] P.M. Coutinho, B. Henrissat, Carbohydrate-Active Enzymes server
at URL: http://afmb.cnrs.mrs.fr/Vpedro/CAZYdb.html, 1999.
[5] C. Busch, F. Hofmann, J. Selzer, S. Munro, D. Jeckel, K. Aktories,
A common motif of eukaryotic glycosyltransferases is essential for
the enzyme activity of large clostridial cytotoxins, J. Biol. Chem. 273
(1998) 19566^19572.
[6] C.A.R. Wiggins, S. Munro, Activity of the yeast MNN1 K-1,3-man-
nosyltransferase requires a motif conserved in many other families of
glycosyltransferases, Proc. Natl. Acad. Sci. USA 95 (1998) 7945^
7950.
[7] C. Busch, F. Hofmann, R. Gerhard, K. Aktories, Involvement of a
conserved tryptophan residue in the UDP-glucose binding of large
clostridial cytotoxin glycosyltransferase, J. Biol. Chem. 275 (2000)
13228^13234.
[8] C. Garinot-Schneider, A.C. Lellouch, R.A. Geremia, Identi¢cation of
essential amino acid residues in the Sinorhizobium meliloti glucosyl-
transferase ExoM, J. Biol. Chem. 275 (2000) 31407^31413.
[9] U.M. Uº nligil, S. Zhou, S. Yuwaraj, M. Sarkar, H. Schachter, J.M.
Rini, X-ray crystal structure of rabbit N-acetylglucosaminyltransfer-
ase I: catalytic mechanism and a new protein superfamily, EMBO J.
19 (2000) 5269^5280.
[10] U.M. Uº nligil, J.M. Rini, Glycosyltransferase structure and mecha-
nism, Curr. Opin. Struct. Biol. 10 (2000) 510^517.
[11] Y. Zhang, P.G. Wang, K. Brew, Speci¢city and mechanism of metal
ion activation in UDP-galactose L-galactoside K-1,3-galactosyltrans-
ferase, J. Biol. Chem. 276 (2001) 11567^11574.
[12] P.I. Mackenzie, Expression of chimeric cDNAs in cell culture de¢nes
a region of UDP-glucuronosyltransferase involved in substrate selec-
tion, J. Biol. Chem. 265 (1990) 3432^3435.
[13] A. Radominska-Pandya, P.J. Czernik, J.M. Little, Structural and
functional studies of UDP-glucuronosyltransferases, Drug Metab.
Rev. 31 (1999) 817^899.
[14] S. Ha, D. Walker, Y. Shi, S. Walker, The 1.9 AŒ crystal structure of
Escherichia coli MurG, a membrane-associated glycosyltransferase
involved in peptidoglycan biosynthesis, Protein Sci. 9 (2000) 1045^
1052.
[15] S.L. Otten, X. Liu, J. Ferguson, C.R. Hutchinson, Cloning and
characterization of the Streptomyces peucetius dnrQS genes encoding
a daunosamine biosynthesis enzyme and a glycosyltransferase in-
volved in daunorubicin biosynthesis, J. Bacteriol. 177 (1995) 6688^
6692.
[16] S. Gaisser, G.A. Bo«hm, J. Corte¤s, P.F. Leadlay, Analysis of seven
genes from the eryAI-eryK region of the erythromycin biosynthetic
gene cluster in Saccharopolyspora erythraea, Mol. Gen. Genet. 256
(1997) 239^251.
[17] A.R. Gandecha, S.L. Large, E. Cundli¡e, Analysis of four tylosin
biosynthetic genes from the tylLM region of the Streptomyces fradiae
genome, Gene 184 (1997) 197^203.
[18] P.J. Solenberg, P. Matsushima, D.R. Stack, S.C. Wilkie, R.C.
Thompson, R.H. Baltz, Production of hybrid antibiotics in vitro
and in Streptomyces toyocaensis, Chem. Biol. 4 (1997) 195^202.
CHBIOL 104 5-6-01 Cyaan Magenta Geel Zwart
Research Paper Glycosyltransferases in urdamycin biosynthesis D. Ho¡meister et al. 565
[19] R.G. Summers, S. Donadio, M.J. Staver, E. Wendt-Pienowksi, C.R.
Hutchinson, L. Katz, Sequencing and mutagenesis of genes from the
erythromycin biosynthetic gene cluster of Saccharoployspora eryth-
raea that are involved in L-mycarose and D-desosamine production,
Microbiology 143 (1997) 3251^3262.
[20] L.M. Quiro¤s, I. Aguirrezbalaga, C. Olano, C. Me¤ndez, J.A. Salas,
Two glycosyltransferases and a glycosidase are involved in oleando-
mycin modi¢cation during its biosynthesis by Streptomyces antibioti-
cus, Mol. Microbiol. 28 (1998) 1177^1186.
[21] B. Faust, D. Ho¡meister, G. Weitnauer, L. Westrich, S. Haag, P.
Schneider, H. Decker, E. Ku«nzel, J. Rohr, A. Bechthold, Two new
tailoring enzymes, a glycosyltransferase and an oxygenase, involved
in biosynthesis of the angucycline antibiotic urdamycin A in Strepto-
myces fradiae Tu«2717, Microbiology 146 (2000) 147^154.
[22] A. Trefzer, D. Ho¡meister, E. Ku«nzel, S. Stockert, G. Weitnauer, L.
Westrich, U. Rix, J. Fuchser, K.U. Bindseil, J. Rohr, A. Bechthold,
Function of glycosyltransferase genes involved in urdamycin A bio-
synthesis, Chem. Biol. 7 (2000) 133^142.
[23] Y. Volchegursky, Z. Hu, L. Katz, R. McDaniel, Biosynthesis of the
anti-parasitic agent megalomicin: transformation of erythromycin to
megalomicin in Saccharopolyspora erythraea, Mol. Microbiol. 37
(2000) 752^762.
[24] H. Drautz, H. Za«hner, J. Rohr, A. Zeeck, Metabolic products of
microorganisms. 234. Urdamycins, new angucycline antibiotics from
Streptomyces fradiae. I. Isolation, characterization and biological
properties, J. Antibiot. 39 (1986) 1657^1669.
[25] J. Rohr, M. Scho«newolf, G. Udvarnoki, K. Eckhardt, G. Schumann,
C. Wagner, J.M. Beale, S.D. Sorey, Investigations on the biosynthesis
of the angucycline group antibiotics aquayamycin and the urdamy-
cins A and B. Results from the structural analysis of novel blocked
mutant products, J. Org. Chem. 58 (1993) 2547^2551.
[26] H. Decker, S. Haag, Cloning and characterization of a polyketide
synthase gene from Streptomyces fradiae Tu«2717, which carries the
genes for biosynthesis of the angucycline antibiotic urdamycin A and
a gene probably involved in its oxygenation, J. Bacteriol. 177 (1995)
6126^6136.
[27] D. Ho¡meister, K. Ichinose, S. Domann, B. Faust, A. Trefzer, G.
Dra«ger, A. Kirschning, C. Fischer, E. Ku«nzel, D.W. Bearden, J.
Rohr, A. Bechthold, The NDP-sugar co-substrate concentration
and the enzyme expression level in£uence the substrate speci¢city
of glycosyltransferases : cloning and characterization of deoxysugar
biosynthetic genes of the urdamycin biosynthetic gene cluster, Chem.
Biol. 7 (2000) 821^831.
[28] A. Vrielink, W. Ru«ger, H.P.C. Driessen, P.S. Freemont, Crystal
structure of the DNA modifying enzyme L-glucosyltransferase in
the presence and absence of the substrate uridine diphosphoglucose,
EMBO J. 13 (1994) 3413^3422.
[29] S. More¤ra, A. Imberty, U. Aschke-Sonnenborn, W. Ru«ger, P.S. Free-
mont, T4 phage L-glucosyltransferase: substrate binding and pro-
posed catalytic mechanism, J. Mol. Biol. 292 (1999) 717^730.
[30] S.J. Charnock, G.J. Davies, Structure of the nucleotide-diphospho-
sugar transferase, SpsA from Bacillus subtilis, in native and nucleo-
tide-complexed forms, Biochemistry 38 (1999) 6380^6385.
[31] L.N. Gastinel, C. Cambillau, Y. Bourne, Crystal structures of the
bovine L4-galactosyltransferase catalytic domain and its complex
with uridine diphosphoglucose, EMBO J. 18 (1999) 3546^3557.
[32] I. Przylas, K. Tomoo, Y. Terada, T. Takaha, K. Fujii, W. Saenger,
N. Stra«ter, Crystal structure of amylomaltase from Thermus aquati-
cus, a glycosyltransferase catalysing the production of large cyclic
glucans, J. Mol. Biol. 296 (2000) 873^886.
[33] N. Ishii, K. Haga, K. Yamane, K. Harata, Crystal structure of as-
paragine 233-replaced cyclodextrin glucanotransferase from alkalo-
philic Bacillus sp. 1011 determined at 1.9 AŒ resolution, J. Mol. Recog.
13 (2000) 35^43.
[34] T. Pillot, M. Ouzzine, S. Fournel-Gigleux, C. Lafaurie, D. Tebbi, S.
Treat, A. Radominska, R. Lester, G. Siest, J. Magdalou, Determi-
nation of the human liver UDP-glucuronosyltransferase 2B4 domains
involved in the binding of UDP-glucuronic acid using photoa⁄nity
labeling of fusion proteins, Biochem. Biophys. Res. Commun. 197
(1993) 785^791.
[35] L. Westrich, S. Domann, B. Faust, D. Bedford, D.A. Hopwood, A.
Bechthold, Cloning and characterization of a gene cluster from Strep-
tomyces cyanogenus S136 probably involved in landomycin biosyn-
thesis, FEMS Microbiol. Lett. 170 (1999) 381^387.
[36] K. Salah-Bey, M. Doumith, J.M. Michel, S. Haydock, J. Corte¤s, P.F.
Leadlay, M.C. Raynal, Targeted inactivation for the elucidation of
deoxysugar biosynthesis in the erythromycin producer Saccharopoly-
spora erythraea, Mol. Gen. Genet. 257 (1998) 542^553.
[37] R.G. Summers, S. Donadio, M.J. Staver, E. Wendt-Pienkowski, C.R.
Hutchinson, L. Katz, Sequencing and mutagenesis of genes from the
erythromycin biosynthetic gene cluster of Saccharopolyspora eryth-
raea that are involved in L-mycarose and D-desosamine production,
Microbiology 143 (1997) 3251^3262.
[38] Y. Volchegursky, Z. Hu, L. Katz, R. McDaniel, Biosynthesis of the
anti-parasitic agent megalomicin: transformation of erythromycin to
megalomicin in Saccharopolyspora erythraea, Mol. Microbiol. 37
(2000) 752^762.
[39] E. Ferna¤ndez, U. Weissbach, C. Sa¤nchez Reillo, A.F. Brana, C.
Me¤ndez, J. Rohr, J.A. Salas, Identi¢cation of two genes from Strep-
tomyces argillaceus encoding glycosyltransferases involved in transfer
of a disaccharide during biosynthesis of the antitumor drug mithra-
mycin, J. Bacteriol. 180 (1998) 4929^4937.
[40] G. Blanco, E. Ferna¤ndez, M.J. Ferna¤ndez, A.F. Brana, U. Weiss-
bach, E. Ku«nzel, J. Rohr, C. Me¤ndez, J.A. Salas, Characterization
of two glycosyltransferases involved in early glycosylation steps dur-
ing biosynthesis of the antitumor polyketide mithramycin by Strep-
tomyces argillaceus, Mol. Gen. Genet. 262 (2000) 991^1000.
[41] C. Olano, A.M. Rodriguez, J.M. Michel, C. Me¤ndez, M.C. Raynal,
J.A. Salas, Analysis of a Streptomyces antibioticus chromosomal re-
gion involved in oleandomycin biosynthesis, which encodes two gly-
cosyltransferases responsible for glycosylation of the macrolactone
ring, Mol. Gen. Genet. 259 (1998) 299^308.
[42] K. Ichinose, D.J. Bedford, D. Tornus, A. Bechthold, M.J. Bibb, W.P.
Revill, H.G. Floss, D.A. Hopwood, The granaticin gene cluster of
Streptomyces violaceoruber Tu«22: sequence analysis and expression in
a heterologous host, Chem. Biol. 5 (1998) 647^659.
[43] C. Olano, N. Lomovskaya, L. Fonstein, J.T. Roll, C.R. Hutchinson,
A two-plasmid system for the glycosylation of polyketide antibiotics:
bioconversion of O-rhodomycinone to rhodomycin D, Chem. Biol. 6
(1999) 845^855.
[44] K. Back, J. Chappell, Identifying functional domains within terpene
cyclases using a domain-swapping strategy, Proc. Natl. Acad. Sci.
USA 93 (1996) 6841^6845.
[45] T. Kushiro, M. Shibuya, Y. Ebizuka, Chimeric triterpene synthase. A
possible model for multifunctional triterpene synthase, J. Am. Chem.
Soc. 121 (1999) 1208^1216.
[46] S. Kaneko, A. Kuno, Z. Fujimoto, D. Shimizu, S. Machida, Y. Sato,
K. Yura, M. Go, H. Mizuno, K. Taira, I. Kusakabe, K. Hayashi, An
investigation of the nature and function of module 10 in a family F/
10 xylanase FXYN of Streptomyces olivaceoviridis E-86 by module
shu¥ing with the Cex of Cellumonas ¢mi and by site-directed muta-
genesis, FEBS Lett. 460 (1999) 61^66.
[47] J.S.H. Tsang, B.C.M. Pang, Identi¢cation of the dimerization domain
of dehalogenase IVa of Burkholderia cepacia MBA4, Appl. Environ.
Microbiol. 66 (2000) 3180^3186.
[48] S. Beil, J.R. Mason, K.N. Timmis, D.H. Pieper, Identi¢cation of
chlorobenzene dioxygenase sequence elements involved in dechlori-
nation of 1,2,4,5-tetrachlorobenzene, J. Bacteriol. 180 (1998) 5520^
5528.
[49] B. Conrad, V. Hoang, A. Polley, J. Hofemeister, Hybrid Bacillus
amyloliquefaciensUBacillus licheniformis K-amylases. Construction
properties and sequence determinants, Eur. J. Biochem. 230 (1995)
481^490.
[50] A. Singh, K. Hayashi, Construction of chimeric L-glucosidases with
CHBIOL 104 5-6-01 Cyaan Magenta Geel Zwart
566 Chemistry & Biology 8/6 (2001) 557^567
improved enzymatic properties, J. Biol. Chem. 270 (1995) 21928^
21933.
[51] L.V. Kumar, C.M. Rao, Domain swapping in human alpha A and
alpha B crystallins a¡ects oligomerization and enhances chaperone-
like activity, J. Biol. Chem. 275 (2000) 22009^22013.
[52] H.D. Mootz, D. Schwarzer, M.A. Marahiel, Construction of hybrid
peptide synthetases by module and domain fusions, Proc. Natl. Acad.
Sci. USA 97 (2000) 5848^5853.
[53] N.O.L. Seto, C.A. Compston, S.V. Evans, D.R. Bundle, S.A. Nar-
ang, M.M. Palcic, Donor substrate speci¢city of recombinant human
blood group A, B and hybrid A/B glycosyltransferases expressed in
Escherichia coli, Eur. J. Biochem. 259 (1999) 770^775.
[54] M. Gilbert, J.R. Brisson, M.F. Karwaski, J. Michniewicz, A.M. Cun-
ningham, Y. Wu, N.M. Young, W.W. Wakarchuk, Biosynthesis of
ganglioside mimics in Campylobacter jejuni OH4384, J. Biol. Chem.
275 (2000) 3896^3906.
[55] C.J. Belunis, C.R.H. Raetz, Biosynthesis of endotoxins. Puri¢cation
and catalytic properties of 3-deoxy-D-mano-octulosonic acid transfer-
ase from Escherichia coli, J. Biol. Chem. 267 (1992) 9988^9997.
[56] F. Flett, V. Mersinias, C.P. Smith, High e⁄ciency intergenic conjugal
transfer of plasmid DNA from Escherichia coli to methyl DNA-
restricting streptomycetes, FEMS Microbiol. Lett. 155 (1997) 223^
229.
[57] M. Bierman, R. Logan, K. O’Brien, E.T. Seno, R. Nagajara Rao,
B.E. Schoner, Plasmid cloning vectors for the conjugal transfer of
DNA from Escherichia coli to Streptomyces spp, Gene 116 (1992) 43^
49.
[58] J. Sambrook, E.F. Fritsch, T. Maniatis, Molecular Cloning: A Lab-
oratory Manual, 2nd edn., Cold Spring Harbor Laboratory Press,
Cold Spring Harbor, NY, 1989.
[59] D.A. Hopwood, M.J. Bibb, K.F. Chater, T. Kieser, C.J. Bruton,
H.M. Kieser, D.J. Lydiate, C.P. Smith, J.M. Ward, H. Schrempf,
Genetic Manipulation of Streptomyces : A Laboratory Manual, The
John Innes Foundation, Norwich, 1985.
CHBIOL 104 5-6-01 Cyaan Magenta Geel Zwart
Research Paper Glycosyltransferases in urdamycin biosynthesis D. Ho¡meister et al. 567
